Aflac Incorporated (AFLAC) - Q1 2007 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report (Form 10-Q) for Aflac Incorporated and subsidiaries for the period ended March 31, 2007. Aflac is a leading provider of supplemental health and life insurance, operating primarily in two segments: Aflac Japan and Aflac U.S.. The financial statements are unaudited but have been reviewed by KPMG LLP.
Key Financial Metrics
| Metric (in millions, except per share) | Q1 2007 | Q1 2006 |
|---|---|---|
| Total Revenues | $3,751 | $3,559 |
| Premiums | $3,156 | $3,005 |
| Net Investment Income | $566 | $524 |
| Net Earnings | $416 | $375 |
| Earnings Per Share (Diluted) | $0.84 | $0.74 |
| Cash Flow from Operations | $1,176 | $1,023 |
| Total Assets | $61,192 | $59,805 |
| Total Liabilities | $52,703 | $51,464 |
| Shareholders' Equity | $8,489 | $8,341 |
| Notes Payable (Debt) | $1,434 | $1,426 |
| Cash and Cash Equivalents | $834 | $1,203 |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 5.4% year-over-year, driven by a 5.0% increase in premiums and an 8.0% increase in net investment income.
- Profitability: Net earnings rose 11.0% to $416 million. Pretax operating earnings increased to $623 million from $558 million.
- Segment Performance:
- Aflac Japan: Pretax operating earnings grew 9.4% to $465 million. Premium income increased 2.6% in dollars (4.9% in yen). However, new annualized premium sales declined 12.3% in dollars due to weak medical sales and consumer anticipation of lower life insurance rates.
- Aflac U.S.: Pretax operating earnings grew 15.0% to $169 million. Premium income increased 10.9%, and new annualized premium sales rose 10.6%.
- Currency Impact: The yen strengthened slightly against the dollar (118.05 at period end vs. 119.11 at year-end 2006), increasing reported assets and liabilities. Management notes that foreign currency translation can distort growth rates.
- Investment Portfolio: Total investments and cash increased to $53.3 billion. The portfolio yield for Aflac Japan was 4.12%, while the U.S. portfolio yield was 7.07%.
Guidance, Outlook, and Risks
- 2007 Guidance: Management targets a 15% to 16% increase in net earnings per diluted share for 2007 compared to 2006. This projection assumes no impact from foreign currency translation and excludes realized investment gains/losses.
- Sales Outlook:
- Japan: Sales are expected to be challenging in the second quarter but may recover with a modest increase in the second half of 2007.
- U.S.: Management expects total new annualized premium sales to increase 6% to 10% for the full year.
- Dividends and Buybacks: The quarterly dividend was increased to $0.185 per share (up from $0.13 in Q1 2006). The company repurchased 5.06 million shares of treasury stock for $241 million during the quarter. Approximately 31.6 million shares remain available for repurchase.
- Key Risks:
- Foreign Exchange: Fluctuations in the yen/dollar rate significantly impact reported results due to the size of the Japan operation.
- Interest Rates: A 100 basis point increase in rates could reduce the fair value of debt securities by approximately $5.4 billion (unrealized).
- Regulatory: New mortality tables in Japan (effective April 2007) are expected to lower premiums for death benefit products. New reserving rules for third-sector products are also being implemented.
- Claims Review: Aflac Japan identified 19,169 payment errors over the last five years, resulting in an additional $16 million in claims payments, most of which were accrued in Q1 2007.
Investor Verification Checklist
- Verify the impact of the new Japanese mortality tables on future premium pricing and sales volume in the second half of 2007.
- Monitor the trend in Aflac Japan's new annualized premium sales, which declined 12.3% in Q1, to assess if the anticipated recovery materializes.
- Review the composition of the investment portfolio, specifically the 68.4% held in privately issued securities, and the $1.07 billion in below-investment-grade securities.
- Track the yen/dollar exchange rate, as a weakening yen would suppress reported earnings growth despite underlying operational performance.
- Confirm the execution of the share repurchase program and the sustainability of the increased dividend payout.